medigraphic.com
SPANISH

Cardiovascular and Metabolic Science

ISSN 2954-3835 (Electronic)
ISSN 2683-2828 (Print)
Antes Revista Mexicana de Cardiología

Ver Revista Mexicana de Cardiología


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 2

<< Back Next >>

Cardiovasc Metab Sci 2022; 33 (2)

Difficult diagnosis infective endocarditis in a pediatric patient: case report

Ferro, Daniela1; Urrutia, Julian2; Cortés, María Camila3; Rodríguez, Sebastián1; Jaramillo, Andrés4
Full text How to cite this article 10.35366/105822

DOI

DOI: 10.35366/105822
URL: https://dx.doi.org/10.35366/105822

Language: English
References: 10
Page: 73-77
PDF size: 236.66 Kb.


Key words:

Infective endocarditis, pediatric assistant, endocarditis, cardiology, echocardiogram.

ABSTRACT

Infective endocarditis (IE) remains a diagnostic challenge because its clinical manifestations are nonspecific and mimic other entities. IE has been extensively studied and documented in adults but less so in children. Here we describe a clinical case of IE that is difficult to diagnose. This is a thirteen-year-old male patient who came to the emergency department of the Hospital Infantil Universitario de San José due to fever for one year, predominantly in the afternoon. The patient has a history of corrected myelomeningocele, Arnold Chiari malformation type 1, neurogenic bladder and hydrocephalus and is a user of the ventriculoatrial shunt. On admission, a urinary tract infection by a multidrug-resistant germ was documented, which was initially considered the cause of his fever. Multiple echocardiograms were performed, all without evidence of IE. However, in addition to fever and ventriculoatrial shunt, Streptococcus mitis bacteremia and positive rheumatoid factor were documented, establishing a definitive diagnosis of IE according to modified Duke criteria. This case illustrates the importance of maintaining a high suspicion of IE, even in patients with an atypical clinical presentation without specific findings for IE and directing additional studies based on the Duke criteria. This requires knowledge of the typical etiologic microorganisms as well as the findings that constitute the vascular and immunologic phenomena contemplated in the modified Duke criteria.



INTRODUCTION

Infective endocarditis (IE) is defined as the microbial infection of the endocardium, whether in previously healthy hearts or in susceptible ones with risk factors, like instrumentalization.1 Nowadays, IE mainly affects patients with congenital cardiopathies, whereas it was previously more common in those with rheumatic cardiomyopathy.2

IE is an important disease in the paediatric population, despite having a considerably lower incidence and mortality than adults.3 The incidence among children with congenital heart disease has been reported to be between 40 and 60 cases per 100,000 such children.4 Its mortality rates are still significant (5-10% in children) despite the progress in the diagnosis and treatment.5 Here, the case of a male 13-year-old patient with fever is present, multiple comorbidities, positive urine and blood cultures, but no evidence of vegetations on echocardiograms, which led to a delay in the diagnosis.



CASE PRESENTATION

The case involves a 13-year old male patient who presented to the emergency department of the Hospital Infantil Universitario de San José redirected from the neurosurgery outpatient consult due to longstanding fever, predominantly in the evening, of 39-40 oC, which began after a ventriculoatrial shunt which had been performed year earlier. Relevant medical history includes a correction of myelomeningocele in 2007, type 1 Arnold Chiari malformation, neurogenic bladder for which he receives prophylaxis with trimethoprim-sulfamethoxazole, chronic constipation, flaccid paraparesis and hydrocephalus initially treated with a ventriculoperitoneal shunt, which was subsequently changed to a ventriculoatrial shunt.

On admission, the patient presented no other additional symptoms. On physical examination, he was found to be tachycardic and febrile. A working diagnosis of systemic inflammatory response syndrome of unknown origin was established, for which he was admitted for observation. Initial laboratory testing showed leukocytosis, highly C reactive protein, urine analysis with pyuria, bacteriuria, positive leukocyte esterase and microscopic haematuria. An abdominal echography showed splenomegaly and enlarged kidneys. Because of his medical background, a urinary tract infection (UTI) was diagnosed, and a measurement of procalcitonin was ordered, which came back positive. Urine cultures isolate E. coli with an AmpC (serin-betalactamasas) resistance profile, which prompted treatment with ceftriaxone.

The patient had already had a transthoracic echocardiogram (TTE) performed on an outpatient basis, which showed no anomaly. Nevertheless, the study was repeated, documenting free pericardial fluid of 2 mm, with no vegetations or other findings. However, pediatric infectiology considered that regardless of the absence of vegetations infective endocarditis must be suspected and requested additional studies.

On the fifth day of hospitalization, blood cultures isolated Streptococcus mitis penicilin sensitive. Additionally, bone scintigraphy that had been performed on an outpatient basis showed nonspecific hyperuptake. Paediatric rheumatology was therefore consulted, who ordered a rheumatoid factor (RF) that was reported positive on day six of hospitalization. With these last findings, and although no vegetations were documented on TTE, the patient was considered to have confirmed infective endocarditis on account of meeting one major criteria (S. mitis bacteremia) and three minor criteria (fever > 38 oC, predisposing heart condition and positive RF) of the modified Duke criteria. Therefore, it was decided to finish seven days of ceftriaxone for the UTI and then initiate antibiotics for the EI with crystalline penicillin for six weeks. As suggested by the pediatric infectious disease consultant since the culprit organism was sensitive to this treatment. The patient response to treatment was favorable with no new febrile peaks, so during the second week of targeted antibiotic therapy the patient was transferred home to complete the remainder of the treatment under a hospitalization-at-home model in charge of healthcare professionals designated by his health insurance company. He subsequently continued to be followed for his multiple comorbidities on an outpatient basis without evidence of recurrence of the IE.



DISCUSSION

In the present clinical case, the diagnosis of IE was made with the modified Duke criteria. According to the literature, it is not frequent to have a patient with all the clinical findings; for instance, Osler nodes and Janeway lesions are found only in 2.7% and 1.6% of patients with IE, respectively.1 This case was a diagnostic challenge due to the multiple medical comorbidities, which led to the treating physicians towards erroneous diagnoses, like urinary tract infection and renal abscess. A case report was found of a patient with a history of hydrocephalus corrected with VA shunt (ventriculotrial shunt), Arnold Chiari type 2 malformation, myelomeningocele and glomerulonephritis that after 14 years of the placement of the valve developed IE, which guides to confirm the relevance of such record in this case.6

It is crucial to consider IE in the presence of fever of unknown origin, which is found in 90% of all cases associated with risk factors. However, in this instance, despite the fact that pediatric infectology suggested this diagnosis, cardiology did not consider it due to the absence of vegetations on cardiac image and by distractors that suggested other sources of infection. The placement of the AVD a year ago and the subsequent onset of fever was not taken into proper consideration. These findings pointed to IE from the beginning and should not have been disregarded despite a negative echocardiogram.

According to the reviewed literature, echocardiograms should always be interpreted in the light of clinical findings and blood cultures. Therefore, the presence of a normal image does not rule out the existence of IE, as sensitivity is 75% and specificity is 90%.8 It is recommended that if clinical suspicion is high normal TTE should be followed up with a transesophageal echocardiogram (TEE), which has a sensitivity of 90%. Despite, in childhood TEE is rarely needed, it can help in cases such as: aortic root abscess, prosthetic valves, chest wall deformity and obesity. Unfortunately, this test was not performed because the patient's health insurance did not authorize it. In the absence of images showing myocardial compromise, the presence of other findings that suggest heart disease, such as clinical signs or symptoms of heart failure or elevations in pro-BNP levels, should increase the index of suspicion. The patient in this case did not present such clinical findings and the pro-BNP (brain natriuretic peptide) was not documented because this lab test was authorized by his health insurance. However, not all patients with IE develop heart failure or may do so only late in the disease course. Therefore, the absence of such findings does not rule out IE. Nevertheless, in the absence of direct evidence of myocardial involvement, as in this case, it is necessary to differentiate simple bacteremia from IE. The modified Duke criteria are an invaluable tool in this sense as they allow us to make this difficult differential diagnosis. Bacteremia with a typical organism meets a major criteria, but is not by itself sufficient to establish a diagnosis of definitive IE. Instead, at least one other major or three minor criteria must also be met. (The modified Duke criteria even indicate that definitive IE should be diagnosed if five minor criteria are present, even in the absence of any major criteria.) As described above, this patient met one major criteria and three minor criteria, so a diagnosis of definitive IE rather than simple bacteremia is justified according to the modified Duke criteria (Table 1).

Regarding treatment, IE, like many diseases in pediatrics, there is insufficient evidence to allow adequate comparison between alternative therapies. Treatment regimens are therefore chosen on the basis of regimens used for the adult population, with the first line of empirical treatment being ampicillin/sulbactam and aminoglycosides according to American Heart Association (AHA) guidelines.4 Comparing AHA 2015 guidelines and European Society of Cardiology (ESC) guidelines, it can be seen that both of them recommend the use of bactericides over bacteriostatics.3,9 Regarding treatment, AHA recommends IV medication for a treatment period of four-eight weeks.10 As for the case, the change of antibiotic was made due to the resolution of the UTI and the sensitivity shown by the cultures.



CONCLUSIONS

A normal echocardiogram does not exclude the diagnosis of endocarditis, and a repeat echocardiogram may be indicated.

In the clinical scenario, there may be multiple antecedents together with non-specific clinical manifestations that may lead to other etiologies and to an erroneous diagnosis, leading to a delay in the appropriate treatment, so management should always be multidisciplinary.

Transesophageal echocardiography is a very useful diagnostic tool in this type of case in which we have negative transthoracic echocardiograms.

Acknowledgement: To Doctor Keerby Hernandez Pediatrics Cardiologist for the guidance of this report.


REFERENCES

  1. Cox DA, Tani LY. Pediatric infective endocarditis. Pediatr Clin North Am. 2020; 67 (5): 875-888.

  2. Olivera Avezuela C, Lubian Lopez S. Endocarditis infecciosa-tratamiento y profilaxis. Protoc Diagnósticos Ter Cardiol Pediátrica. 2005; 24: 1-14.

  3. Dixon G, Christov G. Infective endocarditis in children: an update. Curr Opin Infect Dis. 2017; 30 (3): 257-267.

  4. Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the american heart association. Circulation. 2015; 132 (15): 1487-1515.

  5. Ogura N, Tomari K, Takayama T, Tonegawa N, Okawa T, Matsuoka T et al. Group A streptococcus endocarditis in children: 2 cases and a review of the literature. BMC Infect Dis. 2019; 19 (1): 102.

  6. Burstrom G, Andresen M, Bartek J, Fytagoridis A. Subacute bacterial endocarditis and subsequent shunt nephritis from ventriculoatrial shunting 14 years after shunt implantation. Case Rep. 2014; 2014: bcr2014204655.

  7. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30 (4): 633-638.

  8. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016; 387 (10021): 882-893.

  9. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Zotti FD et al. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa. Rev Esp Cardiol. 2016; 69 (1): 69e1-e49.

  10. Blomstrom-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG et al. European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the heart rhythm society (HRS), the Asia pacific heart rhythm society (APHRS), the Latin American heart rhythm society (LAHRS), international society for cardiovascular infectious diseases (iscvid) and the european society of clinical microbiology and infectious diseases (ESCMID) in collaboration with the european association for cardio-thoracic surgery (EACTS). Europace. 2020; 22 (4): 515-549.



AFFILIATIONS

1 General Doctor. Member of Centro de Educación y Formación Científica en Pediatría Fundación Universitaria de Ciencias de la Salud Bogotá, Colombia

2 PhD Health Policy. Member of Centro de Educación y Formación Científica en Pediatría Fundación Universitaria de Ciencias de la Salud Bogotá, Colombia.

3 Member of Centro de Educación y Formación Científica en Pediatría Fundación Universitaria de Ciencias de la Salud Medical Intern. Bogotá, Colombia.

4 Member of Centro de Educación y Formación Científica en Pediatría Fundación Universitaria de Ciencias de la Salud Medical Student. Bogotá, Colombia.



Funding/support: The authors deny any type of foundation during the writing of this paper.

Conflict of interests: The authors deny any declaration of interests.



CORRESPONDENCE

Daniela Ferro. E-mail: dferro@fucsalud.edu.co




Received: 03/10/2021. Accepted: 16/03/2022

Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cardiovasc Metab Sci . 2022;33